Franca Cantoresi

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study.

Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study.

Journal: Clinical, cosmetic and investigational dermatology

Published: December 13, 2022

Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy.

Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy.

Journal: Expert opinion on biological therapy

Published: July 19, 2021

Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study.

Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study.

Journal: Acta dermato-venereologica

Published: April 27, 2021

Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.

Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.

Journal: Acta dermato-venereologica

Published: December 03, 2020

Emergency dermatology: Three-month experience from an Italian academic outpatient clinic during lockdown for COVID-19 pandemic.

Emergency dermatology: Three-month experience from an Italian academic outpatient clinic during lockdown for COVID-19 pandemic.

Journal: Dermatologic therapy

Published: August 30, 2020

Blue nevus with satellitosis in a pregnant patient.

Blue nevus with satellitosis in a pregnant patient.

Journal: Italian journal of dermatology and venereology

Published: February 12, 2020

Efficacy of imiquimod 3.75% cream for the treatment of solar lentigo.

Efficacy of imiquimod 3.75% cream for the treatment of solar lentigo.

Journal: Dermatologic therapy

Published: January 07, 2020

Clinical evaluation and efficacy of Imiquimod 3.75% cream for the treatment of actinic keratosis, pigmented basal cell carcinomas, and actinic cheilitis.

Clinical evaluation and efficacy of Imiquimod 3.75% cream for the treatment of actinic keratosis, pigmented basal cell carcinomas, and actinic cheilitis.

Journal: Dermatologic therapy

Published: December 23, 2019

Nonmelanoma skin cancer associated with Hydroxyurea treatment: Overview of the literature and our own experience.

Nonmelanoma skin cancer associated with Hydroxyurea treatment: Overview of the literature and our own experience.

Journal: Dermatologic therapy

Published: February 21, 2019

Type I leucocyte adhesion deficiency in Yemenian family managed with appropriate treatment: A case series.

Type I leucocyte adhesion deficiency in Yemenian family managed with appropriate treatment: A case series.

Journal: Dermatologic therapy

Published: November 22, 2018

Sequential methyl-aminolevulinate daylight photodynamic therapy and diclofenac plus hyaluronic acid gel treatment for multiple actinic keratosis evaluation.

Sequential methyl-aminolevulinate daylight photodynamic therapy and diclofenac plus hyaluronic acid gel treatment for multiple actinic keratosis evaluation.

Journal: Dermatologic therapy

Published: June 18, 2018

Sequential treatment of daylight photodynamic therapy and imiquimod 5% cream for the treatment of superficial basal cell carcinoma on sun exposed areas.

Sequential treatment of daylight photodynamic therapy and imiquimod 5% cream for the treatment of superficial basal cell carcinoma on sun exposed areas.

Journal: Dermatologic therapy

Published: February 05, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026